Jingbo Ma

750 total citations
34 papers, 526 citations indexed

About

Jingbo Ma is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Jingbo Ma has authored 34 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Biomedical Engineering and 6 papers in Immunology. Recurrent topics in Jingbo Ma's work include Nanoplatforms for cancer theranostics (11 papers), Advanced Nanomaterials in Catalysis (4 papers) and Extracellular vesicles in disease (4 papers). Jingbo Ma is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Advanced Nanomaterials in Catalysis (4 papers) and Extracellular vesicles in disease (4 papers). Jingbo Ma collaborates with scholars based in China, Australia and Singapore. Jingbo Ma's co-authors include Zhijie Li, Jigang Wang, Chunjin Fu, Haitao Yuan, Keqiang Liu, Jianmin Shen, Chengchao Xu, Zhifen Li, Weiqiang Zhang and Lingyun Dai and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Jingbo Ma

31 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingbo Ma China 16 244 196 104 77 76 34 526
Jingkang He China 12 190 0.8× 176 0.9× 72 0.7× 99 1.3× 99 1.3× 19 457
Emanuela Gentile United States 8 262 1.1× 283 1.4× 122 1.2× 55 0.7× 229 3.0× 12 670
Guan Jiang China 13 159 0.7× 210 1.1× 80 0.8× 85 1.1× 114 1.5× 58 634
Tianjiao Chu China 9 222 0.9× 164 0.8× 75 0.7× 44 0.6× 140 1.8× 19 523
Yikai Han China 8 274 1.1× 112 0.6× 59 0.6× 94 1.2× 154 2.0× 12 581
Jiangkang Xu China 11 320 1.3× 245 1.3× 85 0.8× 79 1.0× 198 2.6× 12 623
Miao Fan China 12 345 1.4× 229 1.2× 200 1.9× 37 0.5× 118 1.6× 19 632
Weirong Kang Hong Kong 9 154 0.6× 133 0.7× 93 0.9× 59 0.8× 68 0.9× 13 354

Countries citing papers authored by Jingbo Ma

Since Specialization
Citations

This map shows the geographic impact of Jingbo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbo Ma more than expected).

Fields of papers citing papers by Jingbo Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingbo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbo Ma. The network helps show where Jingbo Ma may publish in the future.

Co-authorship network of co-authors of Jingbo Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jingbo Ma. A scholar is included among the top collaborators of Jingbo Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingbo Ma. Jingbo Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Haitao, Xiaoxian Wang, Xin Sun, et al.. (2025). A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy. Acta Pharmaceutica Sinica B. 15(6). 3243–3258. 2 indexed citations
2.
Chen, Ali, Wenzhe Chen, Yunmeng Bai, et al.. (2025). Photothermal-triggered non-apoptotic regulated cell death-related pathway regulation boosts systemic antitumor immunity. Materials Today Bio. 35. 102479–102479.
3.
Ma, Jingbo, Liuhai Zheng, Zhifen Li, et al.. (2025). Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies. Journal of Nanobiotechnology. 23(1). 525–525. 1 indexed citations
4.
Xia, Peng, Xiaolong Xu, Ming Tian, et al.. (2025). Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy. Journal of Extracellular Vesicles. 14(4). e70069–e70069. 5 indexed citations
5.
Ding, Yiwei, Jiang Liu, Qiang Jiang, et al.. (2025). A novel endoscopic posterior cervical decompression and interbody fusion technique: Feasibility and biomechanical analysis. Computer Methods and Programs in Biomedicine. 262. 108676–108676.
6.
Yuan, Haitao, Peili Wang, Runhua Zhou, et al.. (2024). Photoimmunotherapy-Induced Pyroptosis Remodels the Microenvironment to Enhance Cancer Immunotherapy. ACS Materials Letters. 6(8). 3750–3762. 2 indexed citations
7.
Yuan, Haitao, Chong Qiu, Xiaoxian Wang, et al.. (2024). Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer. Advanced Materials. 37(4). e2406662–e2406662. 20 indexed citations
8.
Li, Zhifen, Jingbo Ma, Ming Tian, et al.. (2024). Synthesis, biological activity evaluation and mechanism of action of novel bis-isatin derivatives as potential anti-liver cancer agents. Bioorganic & Medicinal Chemistry Letters. 99. 129613–129613. 4 indexed citations
9.
Xu, Wei, Jiayi Yao, Jingbo Ma, et al.. (2024). Characterization of deoxynivalenol dehydrogenase from Pelagibacterium sp. SCN 63–126 and its application. Archives of Microbiology. 207(1). 9–9. 3 indexed citations
10.
Ma, Jingbo, Jingjing Zhang, Xin Sun, et al.. (2024). An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy. Journal of Controlled Release. 370. 501–515. 20 indexed citations
11.
Xia, Peng, Jingbo Ma, Huifang Wang, et al.. (2024). Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity. Advanced Science. 11(31). e2401905–e2401905. 15 indexed citations
12.
Li, Zhifen, Ming Tian, Jingbo Ma, et al.. (2023). Synthesis and biological evaluation of bis-chalcone conjugates containing lysine linker as potential anticancer agents. Journal of Molecular Structure. 1288. 135785–135785. 6 indexed citations
13.
Ma, Jingbo, et al.. (2023). Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC. Journal of Thoracic Disease. 15(6). 3350–3358.
15.
Xia, Peng, Haitao Yuan, Ming Tian, et al.. (2022). Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic. Advanced Functional Materials. 33(7). 27 indexed citations
16.
Yuan, Haitao, Peng Xia, Xin Sun, et al.. (2022). Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis through Tumor Microenvironment Manipulation for Cancer Therapy. Small. 18(41). e2202161–e2202161. 72 indexed citations
17.
Chen, Kun, Xin Peng, Meng Dang, et al.. (2021). General Thermodynamic-Controlled Coating Method to Prepare Janus Mesoporous Nanomotors for Improving Tumor Penetration. ACS Applied Materials & Interfaces. 13(43). 51297–51311. 20 indexed citations
18.
Zhang, Weiqiang, et al.. (2020). <p>Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p/S100A14 Axis</p>. OncoTargets and Therapy. Volume 13. 8715–8722. 13 indexed citations
19.
Ma, Jingbo, Jianmin Shen, Ting Yue, Ziyan Wu, & Xiaoli Zhang. (2020). Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization. European Journal of Pharmaceutical Sciences. 159. 105693–105693. 18 indexed citations
20.
Li, Xinxin, Jing Chen, Jianmin Shen, et al.. (2018). pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor. International Journal of Pharmaceutics. 545(1-2). 274–285. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026